Prevencio’s inclusion in ACC's Innovation Hub is an honor and reflects our commitment to advancing innovative, accessible, and accurate AI-driven blood tests for clinical use.”
— Rhonda Rhyne, CEO & Chief Translational Officer
KIRKLAND, WA, UNITED STATES, March 25, 2026 /
EINPresswire.com
/ --
Prevencio
, Inc., a leader in AI-powered blood diagnostics, today announced its selection to participate in the Innovation Hub at the
American College of Cardiology
’s (ACC) 75th Annual Scientific Sessions